o2h discovery
Changodar, India o2hdiscovery.co
From their website, Nov 2026
Work here? Claim this listing
About
o2h discovery is a contract research organisation with integrated drug discovery capabilities for biotech and pharmaceutical clients. It operates from research centres in Ahmedabad, India and Cambridge, UK, and also lists a USA location in Cambridge, Massachusetts.
Services
Target Identification and Validation
Supports target identification and validation within an integrated drug discovery platform.
Hit Identification
Provides hit identification services as part of the drug discovery workflow.
Hit to Lead
Advances identified hits into lead series.
Lead Optimization
Supports lead optimization programs for drug discovery projects.
Targeted protein degradation
Offers targeted protein degradation services.
Fragment-based Drug Discovery
Provides fragment-based drug discovery services.
Knowledge-based drug design and SAR
Uses knowledge-based drug design and SAR to support discovery programs.
Early assessment of in vitro ADMET and PK
Provides early in vitro ADMET and pharmacokinetic assessment.
ADME, DMPK & toxicology
Medicinal Chemistry Services
Offers medicinal chemistry support for drug discovery projects.
Synthetic Chemistry
Provides synthetic chemistry services for complex small molecules.
Peptide synthesis service
Offers peptide synthesis services.
PROTAC Services
Provides PROTAC-related services.
Lipid Nanoparticles (LNPs)
Offers lipid nanoparticle services.
Analytical chemistry
Provides analytical chemistry support for discovery programs.
ADCs – linker/payloads
Supports antibody-drug conjugate linker and payload work.
Biology target engagement and validation
Performs biology work for target engagement and validation.
Assays & in vitro testing
PROTAC NanoBRET/NanoBiT
Offers PROTAC NanoBRET/NanoBiT assays.
Assays & in vitro testing
NaLTSA
Provides NaLTSA services.
Assays & in vitro testing
Genetic engineering
Offers genetic engineering services.
siRNA/shRNA
Supports siRNA and shRNA-related work.
Undruggable targets and genetic benchmarking
Works on undruggable targets and genetic benchmarking.
Biophysical
Provides biophysical assay support.
Assays & in vitro testing
Biochemical
Provides biochemical assay support.
Assays & in vitro testing
Cellular
Provides cellular assay support including proliferation, viability, cytotoxicity, 3D cultures and signaling studies.
Assays & in vitro testing
Gene expression
Provides gene expression assays including qRT-PCR and luciferase reporter assays.
Assays & in vitro testing
Drug-Drug interactions and synthetic lethality
Supports drug-drug interaction and synthetic lethality studies.
Assays & in vitro testing
Biomarker assessment
Provides biomarker assessment services.
Assays & in vitro testing
Site-directed mutagenesis & binding studies
Performs site-directed mutagenesis and binding studies.
Assays & in vitro testing
Drug Screening
Offers iterative, primary, orthogonal, selectivity, fragment-based and phenotypic screening.
Assays & in vitro testing
DMPK in-vitro ADME
Provides in-vitro ADME screening services.
ADME, DMPK & toxicology
- Turnaround
- 2 weeks · Get peptides delivered in 2 weeks
Capabilities
- Assays and studies
- Peptides · Custom synthesis · Small molecules · ADME · Peptide synthesis · LNP · High-content imaging · PK/PD · ADCs · SPR · Surface Plasmon Resonance · Fluorescence Polarization (FP)
17 more
Thermal Shift Assay · Enzymes · Fluorescence and Luminescence-based studies · ELISA/AlphaLISA · Proliferation, viability and cytotoxicity · 3D cultures · Intracellular signaling · Mechanism of Action (MoA) · Cell cycle analysis · Cell population analysis · Gene expression · qRT-PCR · Fluorescence Polarization · ELISA · AlphaLISA · Proliferation · Viability - Scale and capacity
- Gram to Kg · Kilo-lab · Non-GMP · GMP [partnership] · Small quantities of a few milligrams · Gram scale · Up to 50-mer linear peptides · Scale-up up to 200L · 500 FTEs
- Therapeutic areas
- Immuno-Oncology · Psychedelics
Instruments and platforms
- Surface Plasmon Resonance
- NanoBRET
- NanoBiT
- High-content imaging
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Peptide · Oligonucleotide · LNP / formulation
Industries served
- Biotech
- Life sciences
Company
- Type
- CRO
- Founded
- 2004
Locations
- Address
- covering 42 FTEs for a UK-based collaborator. He has worked with client
- Sites
- Ahmedabad, India · Cambridge, UK · Cambridge, MA, United States
- Serves
- Europe, USA, Japan, global
Similar labs
Work here? Claim this listing